Preoperative Study of the Correlation Between BDNF-TrkB Signaling Pathway Expression Levels in Cerebrospinal Fluid and Blood and Postpartum Depression
1 other identifier
observational
200
1 country
1
Brief Summary
This single-center prospective observational study will screen 200 parturients with combined lumbo-epidural anesthesia in the First People's Hospital of Lianyungang City, collect the basic information of the patients, as well as the scores of PSQI, STAI, NRS, SSRS and other scales one day before surgery, and analyze their effects on the expression level of BDNF. On the day of surgery, 10mL of peripheral arterial blood and 3 mL of cerebrospinal fluid were collected, and the expression levels of BDNF-TrkB signaling pathway (ProBDNF, mBDNF, TrkB, P-CREB and ALB) were measured, respectively. The patient's EPDS and HAMD-21 scores were evaluated and collected by a professional psychologist at 1 day before surgery, 7 days after surgery, and 42 days after surgery, and the correlation between BDNF expression level and the occurrence of postpartum depression was statistically analyzed, as well as which in cerebrospinal fluid and blood was more sensitive for predicting postpartum depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2025
CompletedFirst Posted
Study publicly available on registry
April 27, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 16, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 16, 2025
CompletedDecember 2, 2025
November 1, 2025
7 months
April 12, 2025
November 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation between the expression level of BDNF-TrkB signaling pathway (mBDNF, proBDNF) in cerebrospinal fluid and blood and postpartum depression;
Blood and cerebrospinal fluid samples were collected before anesthesia administration on the day of surgery, placed in a -80 degree Celsius freezer, and mBDNF and proBDNF concentrations were measured within 3 months after sample collection.
Secondary Outcomes (2)
Comparison of the sensitivity of cerebrospinal fluid and blood levels of BDNF in predicting postpartum depression;
Blood and cerebrospinal fluid samples were collected before anesthesia administration on the day of surgery, placed in a -80 degree Celsius freezer, and BDNF concentrations were measured within 3 months after sample collection.
The correlation between BDNF (mBDNF, proBDNF) concentrations in cerebrospinal fluid and blood.
Blood and cerebrospinal fluid samples were collected before anesthesia administration on the day of surgery, placed in a -80 degree Celsius freezer, and albumin concentrations were measured within 3 months after sample collection.
Eligibility Criteria
Patients undergoing elective cesarean section under combined lumbar-rigid anesthesia in the First People's Hospital of Lianyungang City
You may qualify if:
- Meet the indications for cesarean section and have no contraindications to neuraxial anesthesia;
- years old≤ age ≤ 35 years old;
- ≤ gestational age\< 42;
- American Society of Anesthesiologists (ASA) grade II\~III;
- singleton pregnancy;
- Voluntarily participate in this study and sign the informed consent form.
You may not qualify if:
- Unable to understand the content of the questionnaire correctly;
- a clear history of mental illness, depression, cognitive impairment and other diseases;
- Patients who have been taking sedative, analgesic and psychotropic drugs for a long time;
- Those who have recently used glucocorticoids or immunosuppressants;
- Those who are allergic to or have contraindications to any of the drugs used in this study;
- Serious pregnancy complications, such as preeclampsia, placental hyperplasia, etc.;
- Participated in other clinical studies within the last 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Affiliated Lianyungang Hospital of Xuzhou Medical University
Lianyungang, Jiangsu, 222000, China
Biospecimen
cerebrospinal fluid and blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 12, 2025
First Posted
April 27, 2025
Study Start
May 1, 2025
Primary Completion
November 16, 2025
Study Completion
November 16, 2025
Last Updated
December 2, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share